DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8+ T cells

PLoS Pathog. 2024 Sep 26;20(9):e1012581. doi: 10.1371/journal.ppat.1012581. eCollection 2024 Sep.

Abstract

Epigenetic mechanisms stabilize gene expression patterns during CD8+ T cell differentiation. Although adoptive transfer of virus-specific T cells is clinically applied to reduce the risk of virus infection or reactivation in immunocompromised individuals, the DNA methylation pattern of virus-specific CD8+ T cells is largely unknown. Hence, we here performed whole-genome bisulfite sequencing of cytomegalovirus-specific human CD8+ T cells and found that they display a unique DNA methylation pattern consisting of 79 differentially methylated regions (DMRs) when compared to memory CD8+ T cells. Among the top demethylated DMRs in cytomegalovirus-specific CD8+ T cells was TBKBP1, coding for TBK-binding protein 1 that can interact with TANK-binding kinase 1 (TBK1) and mediate pro-inflammatory responses in innate immune cells downstream of intracellular virus sensing. Since TBKBP1 has not yet been reported in T cells, we aimed to unravel its role in virus-specific CD8+ T cells. TBKBP1 demethylation in terminal effector CD8+ T cells correlated with higher TBKBP1 expression at both mRNA and protein level, independent of alternative splicing of TBKBP1 transcripts. Notably, the distinct DNA methylation patterns in CD8+ T cell subsets was stable upon long-term in vitro culture. TBKBP1 overexpression resulted in enhanced TBK1 phosphorylation upon stimulation of CD8+ T cells and significantly improved their virus neutralization capacity. Collectively, our data demonstrate that TBKBP1 modulates virus-specific CD8+ T cell responses and could be exploited as therapeutic target to improve adoptive T cell therapies.

MeSH terms

  • CD8-Positive T-Lymphocytes* / immunology
  • Cytomegalovirus Infections / genetics
  • Cytomegalovirus Infections / immunology
  • Cytomegalovirus Infections / virology
  • Cytomegalovirus* / genetics
  • Cytomegalovirus* / immunology
  • DNA Methylation*
  • Humans
  • Protein Serine-Threonine Kinases* / genetics
  • Protein Serine-Threonine Kinases* / metabolism

Substances

  • Protein Serine-Threonine Kinases
  • TBK1 protein, human

Grants and funding

This work was supported by the Life Science Foundation (stipend to ZY; www.life-science-stiftung.de), the Friends of the HZI foundation (stipend to VS; www.helmholtz-hzi.de/en/the-hzi/friends-of-the-hzi/activities/), the Helmholtz Association (W2/W3-090 to MMB; www.helmholtz.de), the German Research Foundation (as part of the Research Unit 2830 “Advanced Concepts in Cellular Immune Control of Cytomegalovirus”, grant no 431451204 to BEV; www.dfg.de) and under Germany's Excellence Strategy (EXC 2155, grant no 390874280 to JH; www.dfg.de), and the German Federal Ministry of Education and Science (BMBF; project 01KI2013 to KS and PH; www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.